McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note

Stock Performance - McKesson's stock ended at $602 95, marking a -0 24% decline from the previous day's close [1] - Over the past month, McKesson's shares gained 5 9%, outperforming the Medical sector's 3 83% gain and the S&P 500's 0 81% gain [1] Earnings and Revenue Projections - McKesson is scheduled to release its earnings on February 5, 2025, with projected EPS of$ 8 19, a 5 81% increase from the same quarter last year [2] - Revenue for the upcoming quarter is projected at $95 46 billion, up 18% year-over-year [2] - For the entire year, earnings are forecasted at$ 32 72 per share, a 19 24% increase, and revenue at $358 91 billion, a 16 17% increase compared to the previous year [3] Analyst Estimates and Valuation - Recent adjustments to analyst estimates reflect short-term business dynamics, with positive changes indicating a favorable outlook on the company's profitability [4] - McKesson currently has a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate decreasing by 0 02% over the past month [6] - The company's Forward P/E ratio is 18 47, in line with the industry average [7] - McKesson's PEG ratio is 1 31, lower than the Medical - Dental Supplies industry average of 2 1 [8] Industry Context - The Medical - Dental Supplies industry, part of the Medical sector, has a Zacks Industry Rank of 137, placing it in the bottom 46% of over 250 industries [8] - The Zacks Industry Rank shows that the top 50% of industries outperform the bottom half by a factor of 2 to 1 [9]